Skip to Main Content
 

Global Search Box

 
 
 
 

Files

ETD Abstract Container

Abstract Header

The Novel Biocide AB569 is Effective at Killing the Notorious Combat Wound Pathogens, Multi-Drug Resistant Acinetobacter baumannii and Acinetobacter spp

Abstract Details

2017, MS, University of Cincinnati, Medicine: Molecular Genetics, Biochemistry, and Microbiology.
A novel biocide, AB569 containing acidified nitrite (A-NO2-) and Ethylenediaminetetraacetic Acid (EDTA) combined, has demonstrated bactericidal activity in previous studies with Pseudomonas aeruginosa (Pa) (1) Multi-Drug Resistant Organisms (MDRO) present a challenge to the all-inclusive killing abilities of AB569. Thus, Acinetobacter baumannii (Ab) and Acinetobacter spp. present a model with widely known resistance to antibiotics. Killing studies with AB569 reveal bactericidal action with extended exposure time, 24 to 48 hr, and effective results at key concentrations during shorter inhibitory exposure time, 1 mM EDTA and 32 mM A-NO2-. AB569 as a treatment for Ab is a viable option to prevent bacterial growth, with tests revealing average Fractional Inhibitory Concentration (FIC) concentrations of 0.25 mM EDTA plus 4 mM A-NO2 - across several reference and clinical strains. In addition, toxicity testing on Adult Human Dermal Fibroblasts (HDFa) revealed an upper toxicity limit of 3 mM EDTA plus 64 mM A-NO2 -. AB569 FIC concentrations are within the HDFa cell toxicity range for effective Ab and Acinetobacter spp. treatment. Following treatment with AB569, quantitative PCR revealed up-regulated siderophore production on EDTA treated sample in Siderophore Biosynthesis Non-Ribosomal Peptide Synthetase Module (SBNRPSM) and Siderophore Biosynthesis Protein, Monooxygenase (SBPM) genes compared to untreated control during inhibitory conditions, which was not observed with AB569 treatment. Treating Ab infections with AB569 at inhibitory concentrations reveals the potential clinical benefit of preventing Ab from gaining a growth advantage early in a mixed infection followed by bactericidal activity with extended treatments
Daniel Hassett, Ph.D. (Committee Chair)
Edmund Choi, Ph.D. (Committee Member)
Alison Weiss, Ph.D. (Committee Member)
60 p.

Recommended Citations

Citations

  • Bogue, A. L. (2017). The Novel Biocide AB569 is Effective at Killing the Notorious Combat Wound Pathogens, Multi-Drug Resistant Acinetobacter baumannii and Acinetobacter spp [Master's thesis, University of Cincinnati]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1491557779134504

    APA Style (7th edition)

  • Bogue, Amy. The Novel Biocide AB569 is Effective at Killing the Notorious Combat Wound Pathogens, Multi-Drug Resistant Acinetobacter baumannii and Acinetobacter spp. 2017. University of Cincinnati, Master's thesis. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=ucin1491557779134504.

    MLA Style (8th edition)

  • Bogue, Amy. "The Novel Biocide AB569 is Effective at Killing the Notorious Combat Wound Pathogens, Multi-Drug Resistant Acinetobacter baumannii and Acinetobacter spp." Master's thesis, University of Cincinnati, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1491557779134504

    Chicago Manual of Style (17th edition)